Cargando…
Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the cancers that has the highest morbidity and mortality rates. In clinical practice, there are still many limitations in surveilling, diagnosing, and treating HCC, such as the poor detection of early HCC, the frequent post-surgery recurrence, the low local t...
Autores principales: | Liu, Tingting, Liu, Li, Li, Li, Cai, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457457/ https://www.ncbi.nlm.nih.gov/pubmed/37636988 http://dx.doi.org/10.1016/j.mtbio.2023.100766 |
Ejemplares similares
-
Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2017) -
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
por: Bakrania, Anita, et al.
Publicado: (2021) -
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
por: Chen, Wei, et al.
Publicado: (2021) -
Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2018) -
Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)